Exploring the Skills Gap in Statistical Programming Organizations
Interoperability difficulties resulting from discrepancies in preferred programming languages can be resolved via statistical computing environments.
Exploring an Intelligent Drug Development Paradigm
An intelligent drug development paradigm can enable small pharma to implement an effective early drug development approach.
Microbe Monitoring
Environmental monitoring data can help keep sterile environments sterile.
Teva Pharmaceuticals and Alvotech Expand Existing Biosimilars Partnership
Teva Pharmaceuticals and Alvotech will expand their partnership for the development and commercialization of biosimilar candidates.
Roche and Alnylam Strike $2.8 Billion RNAi Deal
Roche will pay up to $2.8 billion for the rights to Alnylam’s RNA-based hypertension therapeutic.
Sanofi and Recludix Enter STAT6 Inhibitor Partnership Worth More Than $1.3 Billion
Sanofi and Recludix Pharma’s deal centers on developing treatments for various immunological and inflammatory diseases.
Bristol Myers Squibb and Evotec Extend Neuroscience Pact
Under a global license agreement, Bristol Myers Squibb and Evotec will advance the development of neurodegeneration pipeline assets.
Pfizer and Flagship Pioneering Enter Innovation Partnership
The partnership will see Flagship and Pfizer work to create a new pipeline of innovative medicines.
Sanofi and Scribe Therapeutics Expands Genomics Collaboration
The expanded deal, now potentially worth more than $1.2 billion, will work to develop in vivo therapies, including sickle cell disease.
Thermo Fisher Scientific Releases Tumoroid Culture Medium Kit
Thermo Fisher Scientific’s new tumoroid culture medium kit is designed to help cancer researchers better model the disease.
Eurofins Genomics Blue Heron Launches In-Vitro Transcription mRNA Synthesis Service
Eurofins Genomics Blue Heron’s novel mRNA synthesis service is designed for customizable applications.
